Max Kurlbaum

1.0k total citations
47 papers, 603 citations indexed

About

Max Kurlbaum is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Max Kurlbaum has authored 47 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Surgery, 23 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Cancer Research. Recurrent topics in Max Kurlbaum's work include Adrenal and Paraganglionic Tumors (23 papers), Hormonal Regulation and Hypertension (17 papers) and Cancer, Hypoxia, and Metabolism (11 papers). Max Kurlbaum is often cited by papers focused on Adrenal and Paraganglionic Tumors (23 papers), Hormonal Regulation and Hypertension (17 papers) and Cancer, Hypoxia, and Metabolism (11 papers). Max Kurlbaum collaborates with scholars based in Germany, Netherlands and Switzerland. Max Kurlbaum's co-authors include Martin Faßnacht, Matthias Kroiß, Petra Högger, Oliver Scherf‐Clavel, Timo Deutschbein, Sabine Kendl, Stefanie Hahner, Graeme Eisenhofer, Denise Kaden and Thomas Dandekar and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Max Kurlbaum

40 papers receiving 595 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Max Kurlbaum Germany 14 277 259 148 99 67 47 603
Junichi Yamao Japan 14 184 0.7× 64 0.2× 50 0.3× 93 0.9× 19 0.3× 57 679
Robert S. Rosenson United States 13 525 1.9× 368 1.4× 142 1.0× 129 1.3× 8 0.1× 26 961
Matthias Nauck Germany 12 361 1.3× 396 1.5× 78 0.5× 74 0.7× 10 0.1× 17 707
Wen‐Jane Lee Taiwan 13 135 0.5× 97 0.4× 36 0.2× 113 1.1× 38 0.6× 19 641
George Miltiadous Greece 15 415 1.5× 287 1.1× 125 0.8× 105 1.1× 6 0.1× 39 702
Stephen Stewart Ireland 21 118 0.4× 365 1.4× 115 0.8× 276 2.8× 10 0.1× 46 1.8k
Douglas Kling United States 13 596 2.2× 368 1.4× 129 0.9× 207 2.1× 13 0.2× 36 1.3k
J. Oiknine Israel 11 218 0.8× 131 0.5× 55 0.4× 179 1.8× 18 0.3× 12 737
Guiomar Mendieta Spain 17 170 0.6× 104 0.4× 65 0.4× 149 1.5× 8 0.1× 54 723
Αnila Duni Greece 12 91 0.3× 89 0.3× 31 0.2× 125 1.3× 19 0.3× 31 632

Countries citing papers authored by Max Kurlbaum

Since Specialization
Citations

This map shows the geographic impact of Max Kurlbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Kurlbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Kurlbaum more than expected).

Fields of papers citing papers by Max Kurlbaum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Kurlbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Kurlbaum. The network helps show where Max Kurlbaum may publish in the future.

Co-authorship network of co-authors of Max Kurlbaum

This figure shows the co-authorship network connecting the top 25 collaborators of Max Kurlbaum. A scholar is included among the top collaborators of Max Kurlbaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max Kurlbaum. Max Kurlbaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kurlbaum, Max, et al.. (2026). Disruptive effects of phthalates and their substitutes on adrenal steroidogenesis. Frontiers in Endocrinology. 16. 1734184–1734184.
2.
Scheller, Lukas, Max Kurlbaum, Martin Faßnacht, et al.. (2025). In-depth analysis of metabolic hormones and inflammatory markers following Roux-en-Y gastric bypass in humans and rodents: similarities and differences. Diabetes Research and Clinical Practice. 229. 112923–112923.
3.
Trummer, Olivia, Christina Stern, K Mayer-Pickel, et al.. (2024). Steroid Profiles and Precursor-to-Product Ratios Are Altered in Pregnant Women with Preeclampsia. International Journal of Molecular Sciences. 25(23). 12704–12704. 2 indexed citations
4.
Ruggiero, Carmen, Elisa Rossini, Giulia Cantini, et al.. (2023). FSCN1 as a new druggable target in adrenocortical carcinoma. International Journal of Cancer. 153(1). 210–223. 11 indexed citations
5.
Kurlbaum, Max, et al.. (2023). Changes in Plasma Metabolomic Profile Following Bariatric Surgery, Lifestyle Intervention or Diet Restriction—Insights from Human and Rat Studies. International Journal of Molecular Sciences. 24(3). 2354–2354. 4 indexed citations
6.
Müller, Tobias, Thomas Dandekar, Anna Riester, et al.. (2023). Simplified urinary steroid profiling by LC-MS as diagnostic tool for malignancy in adrenocortical tumors. Clinica Chimica Acta. 543. 117301–117301. 10 indexed citations
7.
8.
Isberner, Nora, Anja Gesierich, Bastian Schilling, et al.. (2022). Monitoring of Dabrafenib and Trametinib in Serum and Self-Sampled Capillary Blood in Patients with BRAFV600-Mutant Melanoma. Cancers. 14(19). 4566–4566. 5 indexed citations
9.
Müller, Tobias, Thomas Dandekar, Oliver Scherf‐Clavel, et al.. (2022). Targeted metabolic profiling of urinary steroids with a focus on analytical accuracy and sample stability. SHILAP Revista de lepidopterología. 25. 44–52. 9 indexed citations
10.
Eisenhofer, Graeme, Max Kurlbaum, Mirko Peitzsch, et al.. (2021). The Saline Infusion Test for Primary Aldosteronism: Implications of Immunoassay Inaccuracy. The Journal of Clinical Endocrinology & Metabolism. 107(5). e2027–e2036. 40 indexed citations
11.
12.
Peitzsch, Mirko, Denise Kaden, Max Kurlbaum, et al.. (2021). Harmonization of LC-MS/MS Measurements of Plasma Free Normetanephrine, Metanephrine, and 3-Methoxytyramine. Clinical Chemistry. 67(8). 1098–1112. 21 indexed citations
13.
Kurlbaum, Max, Timo Deutschbein, Mirko Peitzsch, et al.. (2021). Plasma Metabolome Profiling for the Diagnosis of Catecholamine Producing Tumors. Frontiers in Endocrinology. 12. 722656–722656. 8 indexed citations
14.
Isberner, Nora, Sabrina Kraus, Götz Ulrich Grigoleit, et al.. (2021). Ruxolitinib exposure in patients with acute and chronic graft versus host disease in routine clinical practice—a prospective single-center trial. Cancer Chemotherapy and Pharmacology. 88(6). 973–983. 10 indexed citations
15.
Hankir, Mohammed K., Ezgi Eyluel Bankoglu, Ulrich Dischinger, et al.. (2020). Simulating the Post-gastric Bypass Intestinal Microenvironment Uncovers a Barrier-Stabilizing Role for FXR. iScience. 23(12). 101777–101777. 5 indexed citations
16.
17.
Eisenhofer, Graeme, Mirko Peitzsch, Denise Kaden, et al.. (2018). Reference intervals for LC-MS/MS measurements of plasma free, urinary free and urinary acid-hydrolyzed deconjugated normetanephrine, metanephrine and methoxytyramine. Clinica Chimica Acta. 490. 46–54. 60 indexed citations
18.
Kroiß, Matthias, Silviu Sbiera, Sabine Kendl, Max Kurlbaum, & Martin Faßnacht. (2016). Drug Synergism of Proteasome Inhibitors and Mitotane by Complementary Activation of ER Stress in Adrenocortical Carcinoma Cells. Hormones and Cancer. 7(5-6). 345–355. 13 indexed citations
19.
Kurlbaum, Max, et al.. (2013). Facilitated Uptake of a Bioactive Metabolite of Maritime Pine Bark Extract (Pycnogenol) into Human Erythrocytes. PLoS ONE. 8(4). e63197–e63197. 25 indexed citations
20.
Kurlbaum, Max & Petra Högger. (2010). Plasma protein binding of polyphenols from maritime pine bark extract (USP). Journal of Pharmaceutical and Biomedical Analysis. 54(1). 127–132. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Junichi Yamao Breakdown of academic impact, for papers by Robert S. Rosenson Breakdown of academic impact, for papers by Matthias Nauck Breakdown of academic impact, for papers by Wen‐Jane Lee Breakdown of academic impact, for papers by George Miltiadous Breakdown of academic impact, for papers by Stephen Stewart Breakdown of academic impact, for papers by Douglas Kling Breakdown of academic impact, for papers by J. Oiknine Breakdown of academic impact, for papers by Guiomar Mendieta Breakdown of academic impact, for papers by Αnila Duni
Rankless by CCL
2026